Sisi Chan

Investors quietly pile into a group of stocks for 2026 (it’s not tech)

Amid the dominance of technology stocks, healthcare companies have subtly begun to outperform. A pattern of underweight investment in healthcare is making way for more significant funding as several dynamics make the sector a key target for the coming year.

The author’s background lies in sector and industry money flow research. With the help of his proprietary stocks and sector ranking tool, he breaks down statistics allowing readers to understand the shifting investment landscape.

As of December 27, 2025, Limelight Alpha Sector Ranking highlights the recent performance of healthcare stocks, which initially lagged but have now begun to gain momentum. A visual aid and reference link provide comprehensive details.

The key takeaways: Despite the overwhelming tech presence in the S&P 500, diversification through potential healthcare investment makes for a sensible strategy. Major tech names mentioned add relevance to the ongoing discussion.

A model that aggregates individual scores on 1,600 stocks is used to rank sectors. The healthcare sector is emerging as a promising prospect despite potential regulatory challenges within the United States.

Despite the volatile economic climate, the author asserts that investing in healthcare stocks could offer stability. A visual representation supports this statement, illustrating the potential benefits of healthcare investment during uncertain times.

The current interest in healthcare sector investments can be largely attributed to the following reasons:

• Regulatory policy stability;
• Revenue growth;
• Stable margins;
• Low infection-driven closures;
• Developments in telehealth.

Authored by Todd Campbell and Daniel Kline, the Co-Editors-in-Chief of The Street, this article offers authoritative insights into the potential boom in healthcare investments for 2026.